Status: Not yet recruiting
A Phase I First-in-human Trial of Bvax (B-cell Vaccination) in Addition to Standard of Care Chemoradiotherapy for Newly Diagnosed Glioblastoma
The objectives of this phase I first-in-human trial are to evaluate safety, feasibility, and preliminary efficacy of an individualized Bvax vaccine in addition to standard of care chemoradiation in patients with newly diagnosed glioblastoma.
Participants needed: 25
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Catalina Lee ChangUpdated: Sep 25, 2026Locations: 1
Eligibility criteria
Histologically confirmed glioblastoma. [+13]
Have not recovered from adverse events from surgery or the ongoing chemoradiothe... [+10]